DJIA 16,530.53 179.15 1.10%
NASDAQ 4,790.60 40.62 0.86%
S&P 500 1,973.68 24.82 1.27%
market minute promo

ImmunoGen (NASDAQ: IMGN)

13.41 -0.05 (-0.37%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IMGN $13.41 -0.37%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $13.42
Previous Close $13.46
Daily Range $13.26 - $13.61
52-Week Range $5.34 - $19.43
Market Cap $1.2B
P/E Ratio -18.96
Dividend (Yield) $0.00 (0.0%)
Volume 209,325
Average Daily Volume 1,192,783
Current FY EPS -$1.42

Sector

Healthcare

Industry

Drug Makers

ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website: http://www.immunogen.com/

News & Commentary

Why Shares of ImmunoGen Inc Were Up Big Today

Shares of the cancer focused small-cap were up today on an otherwise down day for the markets.

Perilous Reversal Watch: Immunogen (IMGN)

ImmunoGen Inc: Finally Targeting Strong Returns?

This long-time sleepy stock has woken up recently on a flurry of good news. Does the future finally look bright for investors?

Why Cantor's Mara Goldstein Just Downgraded ImmunoGen

Benzinga's Top Downgrades

Analysts' Actions -- Bunge, Coach, Realogy and More

ImmunoGen: Back to a Development-Stage Biotech

With the biotech no longer collecting Kadcyla royalties, the pipeline becomes the focus of the release of quarterly earnings.

ImmunoGen's (IMGN) CEO Dan Junius on Q4 2015 Results - Earnings Call Transcript

ImmunoGen (IMGN) Q2 2015 Results - Earnings Call Webcast

ImmunoGen Is Climbing Higher... Again

ImmunoGen's shares continue to gain ground in the wake of early-stage trial results for its ovarian cancer drug.

See More IMGN News...

IMGN's Top Competitors

IMGN $13.41 (-0.37%)
Current stock: IMGN
AMGN $152.23 (-0.04%)
Current stock: AMGN
GILD $104.09 (-0.17%)
Current stock: GILD
BIIB $309.07 (1.60%)
Current stock: BIIB